(NU/1433-30) CAF1 - A robust, easily engineered polymer with applications in synthetic biology: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
What the buyer wrote
Caf1 is secreted from the bacterium Yersinia pestis to protect it from white blood cells during infection. It is formed from 15 kDa monomers that produce robust, flexible polymers up to 2 µm in length. We aim to create a spinout company that will initially produce Caf1 polymers and coated plasticware/microcarriers for the 2D cell culture market, predominantly focussed on laboratory research, expanding into commercial companies looking to scale up cell production. The Newcastle-based company will supply these products directly to customers, and through marketing partners who have established distribution networks. We are looking for a CEO/COO/Chairperson to work alongside Daniel Peters to dev…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- (NU/1433-30) CAF1 - A robust, easily engineered polymer with applications in synthetic biology: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
- How they are buying
- Advertised, shortlist firstSuppliers applied to be considered, and the buyer picked who went on to bid.
- Type
- services
- Dynamic market
- Yes: you can apply to join at any time. How these work
- Where
- in the North East
- Kind of work
- Professional services, Logistics, courier and distribution
Who the buyer named
Natalie Morton was the named contact on this notice.